BDCDA seeks reconsideration of Karnataka Drugs & Cosmetics Rules Amendments: Nandita Vijayasimha, Bengaluru Saturday, January ...
Just-Evotec Biologics receives Gates Foundation grant for AI-driven optimization of monoclonal antibody developability for affordable access: Hamburg, Germany Saturday, January 10 ...
NIHR leaders and researchers recognised in King’s New Year Honours: United Kingdom Saturday, January 10, 2026, 12:00 Hrs [IST] National Institute for Health and Care Research (N ...
Panel asks Ayush Ministry to intensify efforts to clear pending Utilisation Certificates: Gireesh Babu, New Delhi Saturday, January 10, 2026, 08:00 Hrs [IST] Raising concerns over ...
Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...
Pronto Consult observes India’s 2025 healthcare shift from reactive protection to aspirational prevention: Peethaambaran Kunnathoor, Chennai Saturday, January 10, 2026, 08:00 Hr ...
Experts recommend eliminating inverted duty structure, incentives for research in Union Budget 2026: Shardul Nautiyal, Mumbai Saturday, January 10, 2026, 08:00 Hrs [IST] Experts h ...
Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...
Inizio Ignite sparks a new era of connected advisory solutions to accelerate pharmaceutical performance: Chicago Friday, January 9, 2026, 18:00 Hrs [IST] Inizio, a leading global ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in ...